Lipoprotein-Associated Phospholipase A2 Loss-of-Function Variant and Risk of Vascular Diseases in 90,000 Chinese Adults

J Am Coll Cardiol. 2016 Jan 19;67(2):230-231. doi: 10.1016/j.jacc.2015.10.056.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • 1-Alkyl-2-acetylglycerophosphocholine Esterase / genetics*
  • Arterial Occlusive Diseases / complications
  • Arterial Occlusive Diseases / drug therapy
  • Arterial Occlusive Diseases / genetics*
  • Arterial Occlusive Diseases / metabolism
  • Benzaldehydes / pharmacology*
  • China
  • Coronary Disease / etiology
  • Coronary Disease / metabolism
  • Coronary Disease / prevention & control*
  • Female
  • Genetic Predisposition to Disease
  • Humans
  • Male
  • Middle Aged
  • Oximes / pharmacology*
  • Phospholipase A2 Inhibitors / pharmacology
  • Stroke / etiology
  • Stroke / metabolism
  • Stroke / prevention & control*

Substances

  • Benzaldehydes
  • Oximes
  • Phospholipase A2 Inhibitors
  • 1-Alkyl-2-acetylglycerophosphocholine Esterase
  • darapladib